Corvus Pharmaceuticals
Utility Patents
Last updated:
List of all Corvus Pharmaceuticals patents 9 in total
| Status | Patent |
|---|---|
Grant | Utility: Pharmaceutical formulations Filling date: 27 Sep 2025 Issue date: 8 Mar 2022 |
Grant | Utility: Compounds and methods for modulating adenosine A2B receptor and adenosine A2A receptor Filling date: 27 Sep 2025 Issue date: 22 Feb 2022 |
Grant | Utility: Methods of treating cancer Filling date: 27 Sep 2025 Issue date: 22 Jun 2021 |
Grant | Utility: Compounds and methods for modulating interleukin-2-inducible t-cell kinase Filling date: 27 Sep 2025 Issue date: 18 May 2021 |
Grant | Utility: Methods of treating cancer Filling date: 27 Sep 2025 Issue date: 9 Feb 2021 |
Grant | Utility: Compounds and methods for modulating bruton's tyrosine kinase Filling date: 27 Sep 2025 Issue date: 22 Dec 2020 |
Grant | Utility: Humanized anti-CD73 antibodies Filling date: 27 Sep 2025 Issue date: 3 Nov 2020 |
Grant | Utility: Anti-CD73 antibodies Filling date: 27 Sep 2025 Issue date: 6 Oct 2020 |
Grant | Utility: Processes for making triazolo[4,5D] pyramidine derivatives and intermediates thereof Filling date: 27 Sep 2025 Issue date: 19 May 2020 |
Showing 1 to 9 of 9 patents.